01 9VERTEX PHARMS INC
01 911752106
01 9Blank
01 9Y
01 92033-02-27
Patent Expiration Date : 2033-02-27
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3696
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3697
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3697
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4052
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3697
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4052
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3697
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207925
Patent Use Code : U-3697
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
Patent Expiration Date : 2033-02-27
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11752106
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3696
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-02-27
